文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 外语学习 > 英语学习 > Molecular diagnosis and therapy of hepatocellularcarcinoma
侵权投诉

Molecular diagnosis and therapy of hepatocellularcarcinoma

科研文献,多多交流

JOURNALOFHEPATOLOGY

[31,32].Here,severalgenomicimbalancesinHCCcelllinescouldtoconductpharmacogenomicanalysisisapromisingapproachtobeassociatedwiththepathogenesisoflivercancertherebypro-predictdrugsensitivityandrationalizetheuseofdrugsthatvidingabasisforarray-basedmoleculardiagnosisandmonitor-alreadyhassuccessfullybeenappliedinseveralstudies[14].ingoflivercancer.Recently,asimilarapproachwasemployedTheeraofwholetranscriptomicanalysesforHCCstartedalmostusinghigh-densitysinglenucleotidepolymorphismarraysand10yearsago[43–45].Sincethen,morethan20clinicallyrelevantuncovered6deletionsand126ampli cationssharedbyseveralgeneexpressionsignatureshavebeengeneratedinHCC(Table2).celllines[33].Moredetailedanalysesofidenti edgenes(FNDC3BTheclinicalutilityofthesestudiesisrangingfromdiagnosisover(3q26.3)andSLC29A2(11q13.2)),previouslynotrecognizedinpredictionofsurvivalandmetastaticspreadtopredictionofthecontextoflivercancer,con rmedconsistentactivationandrecurrentdiseases.

clinicalcorrelationofthesegenesinseveralHCCdatasets.More-Thepowerofgeneexpressionsignaturestocomplementdiag-over,furtherevaluationdemonstratedafunctionalroleforcancernosticstrategiescouldbedemonstratedinseveralstudies.Byuti-cellproliferationandtumorigenicity,supportingtheuseofcelllizingwholetranscriptomeanalyses,arecentstudytriedtolinesfordiscoveryofdiagnosticandtherapeuticbiomarkersdiscriminateandidentifykeyregulatorymoleculesbetweencir-andhighlightingthepowerofwholegenomicapproaches.Sincerhotic(regenerative)nodules,dysplasticnodules(DN),andearlythemajorityofHCCsdevelopovermanyyearsonthebasisofstageHCC[46].Asaresult,theauthorsdemonstratedthatupreg-chronicin ammation,severalredundantstructuralabnormalitiesulationofMYC(8q)indysplasticnodulescouldbeusedasamar-areassociatedwithprimarylivercancerinvolvingchromosomalkerformalignantconversion.Notably,othermarkerscommonlyregionswithknowndrivergenesinHCCsuchasc-MYC,RAS,andassociatedtohepatocarcinogenesis(GPC3)couldalsobep53[21].Acomprehensivecatalogofcommonaberrationsfromdetected.

bothhumanandrodentsisprovidedintheOncoDB.HCCSeveralhallmarkprognosticsignatureshavebeengenerated(doc.guandang.net)database[34].Thisdata-forHCCbyapplyingglobalgeneexpressionanalyses(Table2).baseprovidesauseful,validated,andgraphicalintegrationofConsiderableheterogeneityacrossthesesignaturesresultsinpublisheddataderivedfromLOHanalyses,aCGH,geneexpres-differentnon-overlappingnumbersofgenesanddifferencesinsionmicroarraysaswellasproteomicswhichispublicallyassess-prognosticrelevance.Nevertheless,hallmarksignalingoftumors,ableforvalidationofmoleculartargets.However,duetowellestablishedforthemajorityofsolidtumors,suchasprolifer-moleculardiversityofthealterationsbehindtheseloci,amajorativesignaling,resistanceagainstcelldeath,immortality,obstacleremainsthefunctionalevaluationofindividualgenespro-angiogenicsignaling,activationofinvasiveandmetastaticandidenti cationofdrivergenes.programsaswellaspro-in ammatorysignalingcouldalsobereca-Traditionally,thefunctionalroleofidenti edgeneshasbeenpitulatedforHCC[15,47,48].Otherpathwaysassociatedwithbadstudiedusinggeneticallymodi edmousemodels[35,36].survivalinvolvedlessstudiedpathwayssuchasubiquitination,Althoughthesemousemodelsrevealedimportantinsightsintohistonemodi cationsaswellasstemnesstraits[15,41,themolecularpathogenesisoflivercancer,theyhaveseveral49,50].Sincethen,severaloftheidenti edmarkershavebeenshortcomingsthatlimittheirusefortranslationalmedicine[37].testedfortheirsigni canceastherapeutictargetsandwillbedis-Recently,asystematicstrategytoidentifypotentialdrivercussedlaterinthisreview[51–53].Interestingly,arecentstudygenesbyintegratingwholegenomecopynumberdatawithgenegeneratedaprognosticsignaturefromlivertissueadjacenttotheexpressionpro lesofHCCpatientswasintroduced[38].Bytumor,underliningtheroleofthediseasedmicroenvironmentselectingonlygeneswithprognosticsigni canceinHCCpatients,fortheprogressionoflivercancer[16].Villanuevaetal.usedanatotalof50putativedrivergeneswereidenti edandfunction-integrativeapproachcombiningdifferentpublishedprognosticallyevaluatedbyRNAi.Further,byusingtheconnectivitymapgeneexpressionpro linginHCC.Asaresult,theywereabletoanassociationofthe50geneswithspeci csignalingmoleculescompositeaprognosticmodelforHCCrecurrence,basedongeneinHCCcouldbeestablished(mTOR,AMPK,andEGFR).TheCon-expressionpatternsinanindependentsetoftumorandadjacentnectivitymapisapublicallyavailableandpowerfultoolthatlivertissuescon rmingthepowerofgeneexpressiontocomple-enablesdiscoveryoffunctionalconnectionsbetweendrugsandment ndingsfromclinicalandpathologyanalyses[54].genesusingacollectionofgenome-widetranscriptionalexpres-Severalexamplesfromdifferentsolidtumorsexistonhowsiondatafromculturedhumancellstreatedwithbioactivesmallgene-expressionpro lesmaybeusedinclinicalpracticeforriskmolecules[39,40].predictione.g.ofrecurrentdisease(70-genepro le(Mamma-Insummary,overtherecentdecadesextensivestudiesonPrint)[55],the21-generecurrencescore(OncotypeDX)[56];genomicchangesrevealedrecurrentmolecularchangesassoci-76-geneoutcomeRotterdamsignature[57]).IncaseofHCC,atedwithlivercancer.Availabilityofsystematicandmultidimen-besidesthementionedprognosticsignaturesseveralsignaturessionalapproachesforintegrativegenomicanalysesofwholepredictivefore.g.recurrenceandmetastasishavebeengeneratedgenomesfrombothrodentandhumantumorswillfurtherpro-(Table2).Alreadyin2002,a12-genesignaturewasgeneratedvidenovelinsightsintomolecularmechanismsinlivercancer,thatcouldpredictearlyintrahepaticrecurrence[43].Later,athatarelikelytochangetheclinicalmanagementofthisdisease.groupfromNCIwasabletogeneratea17-geneimmune

response-relatedsignaturefromnon-canceroustissuesinmeta-

Transcriptomicsstaticliversthataccuratelypredictedvenousmetastases,recur-

rence,andprognosisofHCCpatients[58].Althoughallofthese

Theuseofgene-expressionsignaturesisapowerfulaidinthesignatureshadsigni cantpredictiveability,thesuccessfultrans-developmentofnoveldiagnostictoolsandforaccurateandlationandrigorousevaluationforaclinicalapplicationisyettounbiasedidenti cationofprognosticsubclassesandnewcellularbegenerated.

targetsinlivercancer[15,41,42].Moreover,theuseofwholeAnotherusefulapplicationofgeneexpressiondataisthegen-transcriptomedatafrompatientsbeforeandafterdrugtreatmenterationofpublicallyavailabledatabases[59,60].Although

Molecular diagnosis and therapy of hepatocellularcarcinoma

Molecular diagnosis and therapy of hepatocellularcarcinoma

highly

JournalofHepatology2012vol.56j267–275269

上一页第3页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email